Cargando…

The detection, treatment, and biology of epithelial ovarian cancer

Ovarian cancer is particularly insidious in nature. Its ability to go undetected until late stages coupled with its non-descript signs and symptoms make it the seventh leading cause of cancer related deaths in women. Additionally, the lack of sensitive diagnostic tools and resistance to widely accep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gubbels, Jennifer AA, Claussen, Nick, Kapur, Arvinder K, Connor, Joseph P, Patankar, Manish S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856581/ https://www.ncbi.nlm.nih.gov/pubmed/20350313 http://dx.doi.org/10.1186/1757-2215-3-8

Ejemplares similares

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
por: Nayak, Amruta P., et al.
Publicado: (2018)

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
por: Belisle, Jennifer A, et al.
Publicado: (2010)

M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop
por: Carroll, Molly J., et al.
Publicado: (2016)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
por: Gubbels, Jennifer AA, et al.
Publicado: (2006)

Oxidative stress induced by the anti-cancer agents, plumbagin, and atovaquone, inhibits ion transport through Na(+)/K(+)-ATPase
por: Alharbi, Yousef, et al.
Publicado: (2020)

Terpenoids from Zingiber officinale (Ginger) Induce Apoptosis in Endometrial Cancer Cells through the Activation of p53
por: Liu, Yang, et al.
Publicado: (2012)

Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies
por: Goodell, Cara AR, et al.
Publicado: (2009)

DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1
por: Connor, Joseph P, et al.
Publicado: (2012)

Plumbagin-induced oxidative stress leads to inhibition of Na(+)/K(+)-ATPase (NKA) in canine cancer cells
por: Alharbi, Yousef, et al.
Publicado: (2019)

Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src
por: Shahzad, Mian M. K., et al.
Publicado: (2018)

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
por: Felder, Mildred, et al.
Publicado: (2014)

Use of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian Cancer
por: Richard, Scott, et al.
Publicado: (2015)

Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation
por: Kapur, Arvinder, et al.
Publicado: (2016)

Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers
por: Kapur, Arvinder, et al.
Publicado: (2022)

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.
por: Friedlander, M. L., et al.
Publicado: (1985)

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options
por: Borella, Fulvio, et al.
Publicado: (2023)

Polarization-resolved second harmonic generation imaging of human ovarian cancer
por: Campbell, Kirby R., et al.
Publicado: (2018)

Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin
por: Kapur, Arvinder, et al.
Publicado: (2018)

One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
por: Rizzo, Andrea, et al.
Publicado: (2018)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Imaging Collagen Alterations in STICs and High Grade Ovarian Cancers in the Fallopian Tubes by Second Harmonic Generation Microscopy
por: Rentchler, Eric C., et al.
Publicado: (2019)

Epithelial Ovarian Cancer—Varied Treatment Results
por: Millert-Kalińska, Sonja, et al.
Publicado: (2023)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer
por: Kulbe, Hagen, et al.
Publicado: (2019)

Etiology and Pathogenesis of Epithelial Ovarian Cancer
por: Mok, Samuel C., et al.
Publicado: (2007)

Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review
por: Borley, J, et al.
Publicado: (2012)

Role of Collagen Fiber Morphology on Ovarian Cancer Cell Migration Using Image-Based Models of the Extracellular Matrix
por: Alkmin, Samuel, et al.
Publicado: (2020)

Treatment of liver metastases in patients with epithelial ovarian cancer
por: Deng, Hao, et al.
Publicado: (2021)

Stromal alterations in ovarian cancers via wavelength dependent Second Harmonic Generation microscopy and optical scattering
por: Tilbury, Karissa B., et al.
Publicado: (2017)

ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells
por: Yan, Hongchao, et al.
Publicado: (2017)

HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
por: Xiang, Xinran, et al.
Publicado: (2011)

A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers
por: Gockley, Allison, et al.
Publicado: (2022)

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
por: Li, Hua, et al.
Publicado: (2013)

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
por: Sonego, Maura, et al.
Publicado: (2017)

Biologically-Targeted Detection of Primary and Micro-Metastatic Ovarian Cancer
por: Liu, Tracy W., et al.
Publicado: (2013)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Role of lymphangiogenesis in epithelial ovarian cancer
por: Sundar, S S, et al.
Publicado: (2006)

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
por: Gien, Lilian T., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_83ik6j4n2eicjp5r72smkfkioj